(Q37718404)

22 August 2017

1 reference

title

Update in chronic obstructive pulmonary disease 2009. (English)

1 reference

chronic obstructive pulmonary disease

22 August 2017

0 references

Borja G Cosio

1

0 references

author name string

Alvar Agustí

series ordinal

2

1 reference

PubMed ID

20335383

22 August 2017

language of work or name

English

0 references

publication date

1 April 2010

1 reference

American Journal of Respiratory and Critical Care Medicine

22 August 2017

1 reference

22 August 2017

181

1 reference

22 August 2017

7

1 reference

22 August 2017

655-660

1 reference

The natural history of chronic airflow obstruction

22 August 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Investigating the natural history of lung function: facts, pitfalls, and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Prevalence, incidence, and lifetime risk for the development of COPD in the elderly: the Rotterdam study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Sex differences in mortality in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years' research

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

C-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

COPD as a disease of accelerated lung aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Cigarette smoke induces cellular senescence via Werner's syndrome protein down-regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Smad gene expression in pulmonary fibroblasts: indications for defective ECM repair in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Down-regulation of the notch pathway in human airway epithelium in association with smoking and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Cigarette smoke impairs clearance of apoptotic cells through oxidant-dependent activation of RhoA

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Pulmonary epithelial neuropilin-1 deletion enhances development of cigarette smoke-induced emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Matrix metalloproteinase-14 mediates a phenotypic shift in the airways to increase mucin production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Hypothesis: does COPD have an autoimmune component?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Immunologic aspects of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Translational mini-review series on Toll-like receptors: networks regulated by Toll-like receptors mediate innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Inflammation of the airways and lung parenchyma in COPD: role of T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Lung dendritic cell expression of maturation molecules increases with worsening chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

The nature of small-airway obstruction in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Lymphoid follicle cells in chronic obstructive pulmonary disease overexpress the chemokine receptor CXCR3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

How cigarette smoke skews immune responses to promote infection, lung disease and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Bacteria challenge in smoke-exposed mice exacerbates inflammation and skews the inflammatory profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Development and first validation of the COPD Assessment Test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Airflow limitation in smokers is associated with subclinical atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Vascular dysfunction in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Depressive symptoms as predictors of mortality in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Cognitive decline among patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

COPD prevalence is increased in lung cancer, independent of age, sex and smoking history

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

COPD exacerbations: defining their cause and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

The coordination of breathing and swallowing in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Abnormal swallowing reflex and COPD exacerbations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Defective macrophage phagocytosis of bacteria in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Haemophilus influenzae from patients with chronic obstructive pulmonary disease exacerbation induce more inflammation than colonizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Improvement in Resting Inspiratory Capacity and Hyperinflation With Tiotropium in COPD Patients With Increased Static Lung Volumes *

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Tiotropium induced bronchodilation and protection from dynamic hyperinflation is independent of extent of emphysema in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Budesonide and the risk of pneumonia: a meta-analysis of individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Decreased histone deacetylase activity in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Bronchial vascular remodelling in patients with COPD and its relationship with inhaled steroid treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Predicting corticosteroid response in chronic obstructive pulmonary disease using exhaled nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Inhibition of PI3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Roflumilast--an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Clarithromycin prevents smoke-induced emphysema in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Integrating health status and survival data: the palliative effect of lung volume reduction surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Biologic lung volume reduction in advanced upper lobe emphysema: phase 2 results

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Levosimendan enhances force generation of diaphragm muscle from patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

COPD and Lung Cancer Have Come a Long Way …Baby

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Telomere shortening in smokers with and without COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

Heliox Improves Oxygen Delivery and Utilization during Dynamic Exercise in Patients with Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0111UP

10.1164/RCCM.201001-0111UP

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20335383